Kras mutation correlating with circulating regulatory T cells predicts the prognosis of advanced pancreatic cancer patients

Bibliographic Details
Title: Kras mutation correlating with circulating regulatory T cells predicts the prognosis of advanced pancreatic cancer patients
Authors: He Cheng, Guopei Luo, Kaizhou Jin, Zhiyao Fan, Qiuyi Huang, Yitao Gong, Jin Xu, Xianjun Yu, Chen Liu
Source: Cancer Medicine, Vol 9, Iss 6, Pp 2153-2159 (2020)
Publisher Information: Wiley, 2020.
Publication Year: 2020
Collection: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: Kras mutation, pancreatic cancer, prognosis, Tregs, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
More Details: Abstract Purpose Kras mutation and abnormal immune status are associated with pancreatic cancer development and progression. In this study, we evaluated the Kras mutation status in circulating tumor DNA and circulating T cell subsets in a cohort of advanced pancreatic cancer patients. Methods Samples were retrospectively obtained from a series of 210 pathological advanced pancreatic cancer patients between 2012 and 2014. The Kras mutation status was detected in cell‐free circulating tumor DNA (ctDNA) by ddPCR and circulating T cell subsets were analyzed by flow cytometry. Results Univariate analysis found that tumor node metastasis (TNM) stage, chemotherapy, circulating regulatory T cells, CA19‐9 levels, CA125 levels, and KrasG12D and KrasG12V mutations were significantly related to overall survival in advanced pancreatic cancer patients. Multivariate analysis identified that TNM stage (P = .03, HR:1.422), Tregs (P = .004, HR:1.522), CA19‐9 levels (P = .009, HR:1.488), KrasG12D mutation (P = .044, HR:1.353), and KrasG12V mutation (P = .001, HR:1.667) were independent prognostic markers. Furthermore, we found that KrasG12V mutation in ctDNA was correlated with high circulating proportion of Tregs, and patients with both KrasG12V mutation and high levels of Tregs were associated with extremely poor survival in advanced pancreatic cancer. Conclusion KrasG12V mutation was associated with high circulating regulatory T cell levels, and both of them predicted worse prognosis in advanced pancreatic cancer patients.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2045-7634
Relation: https://doaj.org/toc/2045-7634
DOI: 10.1002/cam4.2895
Access URL: https://doaj.org/article/ebf03e4209fe483f865398b6b8184cb5
Accession Number: edsdoj.bf03e4209fe483f865398b6b8184cb5
Database: Directory of Open Access Journals
More Details
ISSN:20457634
DOI:10.1002/cam4.2895
Published in:Cancer Medicine
Language:English